ALPS Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
ALPS Advisors's LMAT Position: Q1 2026 in Review
ALPS Advisors reduced its LeMaitre Vascular (LMAT) stake by 8.1% in Q1 2026, selling an estimated $38.6K and leaving 4,586 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #823.
ALPS Advisors first reported a position in LMAT in Q1 2017 and has held it in 19 quarters since. The position peaked at $654K in Q2 2017. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- ALPS Advisors held 4,586 shares of LeMaitre Vascular worth $501K as of Q1 2026.
- ALPS Advisors sold 405 LeMaitre Vascular shares in Q1 2026, an estimated $38.6K.
- LeMaitre Vascular made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #823 holding.
- ALPS Advisors first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 19 quarters since.
- ALPS Advisors's LeMaitre Vascular position peaked at $654K in Q2 2017.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.